Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion type Assertion NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_head.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion evidence source_evidence_literature NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion SIO_000772 14610217 NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion wasDerivedFrom befree-20150227 NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.
- NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_assertion wasGeneratedBy ECO_0000203 NP261716.RAbDkp7Rm7ylWsrxroz0VrTtdgFGh2DmkMRDgR4bciJvE130_provenance.